This invention relates to the field of bio-based injection molding technology, specifically to a bio-based injection molding compound and its production process, comprising the following raw materials in parts by weight: 80-95 parts matrix resin, 4-6 parts modified reinforcing components, 2-3 parts bio-based crosslinking components, and 2.5 parts bio-based functional additives. The matrix resin is based on
polylactic acid (PLA), compounded with
polybutylene furanate and
polyhydroxyalkanoates to form a ternary bio-based
polyester system. This
system compensates for the
brittleness of PLA at the matrix level, improving elongation at break. The addition of modified reinforcing components enhances the material's rigidity and
heat resistance through nanoscale reinforcement. Furthermore, the
ionic liquid modification improves the compatibility with the matrix interface, preventing the mechanical properties from decreasing due to reinforcing phase agglomeration.
Nanocellulose replaces traditional
glass fiber reinforcement, avoiding wear on the screw and mold, and extending equipment lifespan.